Granulocyte transfusion therapy 2006: The comeback kid?

References

• Bensinger WI, Price TH, Dale DC, et al. The effects of daily recombinant human granulocyte colony-stimulating factor administration on normal granulocyte donors undergoing leukapheresis. Blood 1993; 81: 1883–1888
   PubMed Web of Science ®Google Scholar
• Joos K, Herzog R, Einsele H, Northoff H, Neumeister B. Characterization and functional analysis of granulocyte concentrates collected from donors after repeated G-CSF stimulation. Transfusion 2002; 42: 603–611
   PubMed Web of Science ®Google Scholar
• Bodey GP, Buckley M, Sathe YS, Freireich EJ. Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med 1966; 64: 328–340
   PubMed Web of Science ®Google Scholar
• Freireich EJ, Levin RH, Whang J, et al. The function and fate of transfused leukocytes from donors with chronic myelocytic leukemia in leukopenic recipients. Ann NY Acad Sci 1964; 113: 1081–1089
   PubMed Web of Science ®Google Scholar
• Freireich EJ, Judson G, Levin RH. Separation and collection of leukocytes. Cancer Res 1965; 25: 1516–1520
   PubMed Web of Science ®Google Scholar
• Schiffer CA, Aisner J, Dutcher JP, Wiernik PH. Sustained post-transfusion granulocyte count increments following transfusion of leukocytes obtained from donors with chronic myelogenous leukemia. Am J Hematol 1983; 15: 65–74
   PubMed Web of Science ®Google Scholar
• Schiffer CA, Buchholz DH, Aisner J, Wiernik PH. Clinical experience with transfusion of granulocytes obtained by continuous flow filtration leukopheresis. Am J Med 1975; 58: 373–381
   PubMed Web of Science ®Google Scholar
• Graw RG, Jr, Herzig G, Perry S, Henderson ES. Normal granulocyte transfusion therapy: treatment of septicemia due to gram-negative bacteria. N Engl J Med 1972; 287: 367–371
   PubMed Web of Science ®Google Scholar
• Higby DJ, Yates JW, Henderson ES, Holland JF. Filtration leukapheresis for granulocyte transfusion therapy. Clinical and laboratory studies. N Engl J Med 1975; 292: 761–766
   PubMed Web of Science ®Google Scholar
• Vogler WR, Winton EF. A controlled study of the efficacy of granulocyte transfusions in patients with neutropenia. Am J Med 1977; 63: 548–555
   PubMed Web of Science ®Google Scholar
• Alavi JB, Root RK, Djerassi I, et al. A randomized clinical trial of granulocyte transfusions for infection in acute leukemia. N Engl J Med 1977; 296: 706–711
   PubMed Web of Science ®Google Scholar
• Herzig RH, Herzig GP, Graw RG, Jr, Bull MI, Ray KK. Successful granulocyte transfusion therapy for gram-negative septicemia. A prospectively randomized controlled study. N Engl J Med 1977; 296: 701–705
   PubMed Web of Science ®Google Scholar
• Fortuny IE, Bloomfield CD, Hadlock DC, et al. Granylocyte transfusion: a controlled study in patients with acuute nonlymphocytic leukemia. Transfusion 1975; 15: 548–558
   PubMed Web of Science ®Google Scholar
• Winston DJ, Ho WG, Gale RP. Therapeutic granulocyte transfusions for documented infections. A controlled trial in ninety-five infectious granulocytopenic episodes. Ann Intern Med 1982; 97: 509–515
   PubMed Web of Science ®Google Scholar
• Hogge DE, Dutcher JP, Aisner J, Schiffer CA. Lymphocytotoxic antibody is a predictor of response to random donor platelet transfusion. Am J Heme 1983; 14: 363–370
   PubMed Web of Science ®Google Scholar
• Appelbaum FR, Trapani RJ, Graw RG, Jr. Consequences of prior alloimmunization during granulocyte transfusion. Transfusion 1977; 17: 460–464
   PubMed Web of Science ®Google Scholar
• Dutcher JP, Schiffer CA, Johnston GS, et al. Alloimmunization prevents the migration of transfused indium-111-labeled granulocytes to sites of infection. Blood 1983; 62: 354–360
   PubMed Web of Science ®Google Scholar
• McCullough J, Weiblen BJ, Clay ME, Forstrom L. Effect of leukocyte antibodies on the fate in vivo of indium-111-labeled granulocytes. Blood 1981; 58: 164–170
   PubMed Web of Science ®Google Scholar
• Adkins DR, Goodnough LT, Shenoy S, et al. Effect of leukocyte compatibility on neutrophil increment after transfusion of granulocyte colony-stimulating factor-mobilized prophylactic granulocyte transfusions and on clinical outcomes after stem cell transplantation. Blood 2000; 95: 3605–3612
   PubMed Web of Science ®Google Scholar
• Cesaro S, Chinello P, De Silvestro G, et al. Granulocyte transfusions from G-CSF-stimulated donors for the treatment of severe infections in neutropenic pediatric patients with onco-hematological diseases. Support Care Cancer 2003; 11: 101–106
   PubMed Web of Science ®Google Scholar
• Illerhaus G, Wirth K, Dwenger A, et al. Treatment and prophylaxis of severe infections in neutropenic patients by granulocyte transfusions. Ann Hematol 2002; 81: 273–281
   PubMed Web of Science ®Google Scholar
• Lee JJ, Chung IJ, Park MR, et al. Clinical efficacy of granulocyte transfusion therapy in patients with neutropenia-related infections. Leukemia 2001; 15: 203–207
   PubMed Web of Science ®Google Scholar
• Mousset S, Hermann S, Klein SA, et al. Prophylactic and interventional granulocyte transfusions in patients with haematological malignancies and life-threatening infections during neutropenia. Ann Hematol 2005; 84: 731–734
   Web of Science ®Google Scholar
• Peters C, Minkov M, Matthes-Martin S, et al. Leucocyte transfusions from rhG-CSF or prednisolone stimulated donors for treatment of severe infections in immunocompromised neutropenic patients. Br J Haematol 1999; 106: 689–696
   PubMed Web of Science ®Google Scholar
• Hubel K, Carter RA, Liles WC, et al. Granulocyte transfusion therapy for infections in candidates and recipients of HPC transplantation: a comparative analysis of feasibility and outcome for community donors versus related donors. Transfusion 2002; 42: 1414–1421
   PubMed Web of Science ®Google Scholar
• Kerr JP, Liakopolou E, Brown J, et al. The use of stimulated granulocyte transfusions to prevent recurrence of past severe infections after allogeneic stem cell transplantation. Br J Haematol 2003; 123: 114–118
   PubMed Web of Science ®Google Scholar
• Dignani MC, Anaissie EJ, Hester JP, et al. Treatment of neutropenia-related fungal infections with granulocyte colony-stimulating factor-elicited white blood cell transfusions: a pilot study. Leukemia 1997; 11: 1621–1630
   PubMed Web of Science ®Google Scholar
• Safdar A, Hanna HA, Boktour M, et al. Impact of high-dose granulocyte transfusions in patients with cancer with candidemia: retrospective case-control analysis of 491 episodes of Candida species bloodstream infections. Cancer 2004; 101: 2859–2865
   PubMed Web of Science ®Google Scholar
• Schiffer CA, Aisner J, Daly PA, Schimpff SC, Wiernik PH. Alloimmunization following prophylactic granulocyte transfusion. Blood 1979; 54: 766–774
   PubMed Web of Science ®Google Scholar
• Vij R, DiPersio JF, Venkatraman P, et al. Donor CMV serostatus has no impact on CMV viremia or disease when prophylactic granulocyte transfusions are given following allogeneic peripheral blood stem cell transplantation. Blood 2003; 101: 2067–2069
   PubMed Web of Science ®Google Scholar